Alain Schreiber, Director, 10% Owner at EAGLE PHARMACEUTICALS, INC. (EGRX), bought 2,261,319 shares at $15.00 ($5.0M) on 2014-02-18, disclosed to the SEC on 2014-02-20.
Open-market purchase of $5.0M EGRX by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,927,986 | $0 | 0.0% |
| 2 | $15.00 | 333,333 | $5.0M | 100.0% |
| Total | $2.21 avg | 2,261,319 | $5.0M | 100% |
| Filing → |
| IMDZ | SELL | 2015-04-16 | $1.5M | — | Filing → |
| IMDZ | SELL | 2015-03-12 | $3.2M | — | Filing → |
| AVNR | SELL | 2009-08-13 | $3.2M | — | Filing → |